Anterior visual pathway gliomas: The last 30 years

Seminars in Ophthalmology

Volumn 21, Issue 3, 2006, Pages 117-124

  Pepin, Susan M ^a   Lessell, Simmons ^a  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

Chemotherapy; Glioma; Neurofibromatosis 1; Optic chiasm; Optic nerve; Radiation

Indexed keywords

BIOPSY; CARCINOGENESIS; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; GLIOMA; HIGH RISK PATIENT; HUMAN; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC CHIASM; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; PROTON THERAPY; RADIATION DOSE; REVIEW; STEREOTAXIC SURGERY; TUMOR LOCALIZATION; VISUAL SYSTEM;

ANIMALS; ANTINEOPLASTIC AGENTS; DISEASE MODELS, ANIMAL; GLIOMA; HUMANS; NEUROFIBROMATOSIS 1; OPTIC CHIASM; OPTIC NERVE NEOPLASMS; RADIOTHERAPY, CONFORMAL; VISUAL PATHWAYS;

EID: 33747596400     PISSN: 08820538     EISSN: 17445205     Source Type: Journal    
DOI: 10.1080/08820530500350449     Document Type: Review

References (55)

1. Aarabi B, Long D, et al. Enlarging optic chiasmal glioma with stable visual acuity. Surg Neurol 1978; 10:175-7.
2. Alvord E, Lofton S. Gliomas of the optic nerve or chiasm. Outcome by patients' age, tumor site, and treatment. J Neurosurg 1988; 68:85-98.
3. Astrup J. Natural history and clinical management of optic pathway glioma. British Journal of Neurosurgery 2003; 17(4):327-35.
4. Atlas S. 2002. Magnetic Resonance Imaging of the Brain and Spine, third ed., pp. 1326-1327. Philadelphia, Lippincott Williams and Wilkins.
5. Bajenaru M, Garbow, J, et al. Natural history of neurofibromatosis 1-associated optic nerve glioma in mice. Ann Neurol 2005; 57:119-27.
6. Bajenaru M, Hernandez, M, et al. Optic nerve glioma in mice requires astrocyte Nf1 gene inactiviation and Nf1 brain heterozygosity. Cancer Research 2003; 63:8573-7.
7. Balcer L, Liu G, et al. Visual loss in children with neurofibromatosis type 1 and optic pathway gliomas: relation to tumor location by magnetic resonance imaging. American Journal of Ophthalmology 2001; 131(4):442-5.
8. Borit A., Richardson J. The biological and clinical behaviour of pilocytic astrocytomas of the optic pathways. Brain 1982; 105:161-87.
9. Brodsky M. The "pseudo-CSF" signal of orbital optic glioma on magnetic resonance imaging: a signature of neurofibromatosis. Surv Ophthalmol 1993; 38:213.
10. Burnstine M, Levin L, et al. Nucleolar organizer regions in optic gliomas. Brain 1993; 116:1465-76.
11. Chang CH, Wood EH. 1977. The value of radiation therapy for gliomas of the anterior visual pathway. In R. J. Brockhurst, S. A. Boruchoff, B. T. Hutchinson and S. Lessell (eds.), Controversy in Ophthalmology, pp. 878-886. Philadelphia, W.B. Saunders.
12. Chutorian A, Carter S. 1977. What is the proper management of gliomas of the anterior visual pathway? In R. J. Brockhurst, S. A. Boruchoff, B. T. Hutchinson and S. Lessell (eds.), Controversy in Ophthalmology, pp. 887-896. Philadelphia, W.B. Saunders.
13. Czyzyk E, Sergiusz J, et al. Optic pathway gliomas in children with and without neurofibromatosis 1. Journal of Child Neurology 2003; 18(07):471.
14. Deliganis A, Geyer J, et al. Prognostic significance of type 1 neurofibromatosis (von Recklinghausen Disease) in childhood optic glioma. Neurosurgery 1996; 38:1114-9.
15. DeSousa A, Kalsbeck J, et al. Optic chiasmatic glioma in children. Am J Ophthalmol 1979; 87:376-81.
16. Dutton, JJ. Gliomas of the anterior visual pathway. Surv Ophthalmol 1994; 38(5):427-52.
17. Fletcher W, Imes R, et al. Chiasmal gliomas: appearance and long-term changes demonstrated by computerized tomography. J Neurosurg 1986; 65:154.
18. Flickinger J, Torres C, et al. Management of low-grade gliomas of the optic nerve and chiasm. Cancer 1988; 61:635.
19. Gayre GS, Scott IU, et al. Long-term visual outcome in patients with anterior visual pathway gliomas. J Neuroophthalmol 2001; 21(1):1-7.
20. Glaser J, Hoyt W, et al. Visual morbidity with chiasmal glioma. Long-term studies of visual fields in untreated and irradiated cases. Arch Ophthalmol 1971; 85:3.
21. Glaser JS. 1977. Gliomas of the anterior visual pathways in childhood: rationale for conservative management. In R. J. Brockhurst, S. A. Boruchoff, B. T. Hutchinson and S. Lessell (eds.), Controversy in Ophthalmology, pp. 897-906. Philadelphia, W.B. Saunders.
22. Gottschalk S, Tavakolian R, et al. Spontaneous remission of chiasmatic/hypothalamic masses in neurofibromatosis type 1: report of two cases. Neuroradiology 1999; 41:199-201.
23. Gururangan S, Cavazos C, et al. Phase II study of carboplatin in children with progressive low-grade gliomas. J Clin Oncol 2002; 20:2951-8.
24. Haik B, Louis L, et al. Magnetic resonance imaging in the evaluation of optic nerve gliomas. Ophthalmology 1987; 94:709.
25. Hoffman H, Soloniuk D, et al. Management and outcome of low-grade astrocytomas of the midline in children: a retrospective review. Neurosurgery 1993; 33:964-71.
26. Hug E, Muenter M, et al. Conformal proton radiation therapy for pediatric low-grade astrocytomas. Strehlenther Onkol. 2002; 178:10-7.
27. Imes R, Hoyt W. Magnetic resonance imaging signs of optic nerve gliomas in neurofibromatosis 1. Am J Ophthalmol 1991; 111:729.
28. Jakobiec F, Depot M, et al. Combined clinical and computed tomographic diagnosis of orbital glioma and meningioma. Ophthalmology 1984; 91:137.
29. Jenkin D, Angyalfi S, et al. Optic glioma in children: surveillance, resection, or irradiation? Int J Radiat Oncol Biol Phys 1993; 25:215-25.
30. King A, Listernick R, et al. Optic pathway gliomas in neurofibromatosis type 1: the effect of presenting symptoms on outcome. American Journal of Medical Genetics 2003; 122A:95-9.
31. Kirton A, Kloiber R, et al. Evaluation of pediatric CNS malignancies with 99mTc-Methoxyisobutylisonitrile SPECT. The Journal of Nuclear Medicine 2002; 43(11):14381443.
32. Kortmann R, Timmermann B, et al. Current and future strategies in radiotherapy of childhood low-grade glioma of the brain. Strehlenther Onkol 2003; 179:585-97.
33. Lacaze E, Kieffer V, et al. Neuropsychological outcome in children with optic pathway tumours when first-line treatment is chemotherapy. British Journal of Cancer 2003; 89:2038-44.
34. Lessell S. 1977. Comment: what is the proper management of gliomas of the anterior visual pathway? In R. J. Brockhurst, S. A. Boruchoff, B. T. Hutchinson and S. Lessell (eds.), Controversy in Ophthalmology, pp. 887-896. Philadelphia, W.B. Saunders Company.
35. Listernick R, Charrow J, et al. Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study. J Pediatr 1994; 125:63-6.
36. Listernick R, Charrow J, et al. Intracranial gliomas in neurofibromatosis type 1. American Journal of Medical Genetics 1999; 89:38-44.
37. Listernick R, Lous D, et al. Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force. Ann Neurol 1997; 41:143-9.
38. Liu G, Lessell S. Spontaneous visual improvement in chiasmal gliomas. Am J Ophthalmol 1992; 114:193-201.
39. Massimino M, Spreafico F, et al. High response rate to cisplatin/etoposide regimen in childhood low-grade glioma. J Clin Oncol 2002; 20:4209-16.
40. Massry GG, Morgan CF, et al. Evidence of optic pathway gliomas after previously negative neuroimaging. Ophthalmology 1997; 104(6):930-5.
41. Minokura K, Fujitani K, et al. Infantile optic glioma involving the whole optic pathway - a case report. No Shinkei Geka 1986; 14(5):661-6.
42. Nishihori T, Shirato H, et al. Three-dimensional conformal radiotherapy for astrocytic tumors involving the eloquent area in children and young adults. J Neuro-Oncol 2002; 60:177-83.
43. Packer R, Ater J, et al. Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. J Neurosur 1997; 86:747.
44. Packer R, Lange B, et al. Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood. J Clin Oncol 1993; 11:850-7.
45. Packer R, Sutton L, et al. Treatment of chiasmatic/hypothalamic gliomas of childhood with chemotherapy: an update. Ann Neurol 1988; 23:79.
46. Parsa C, et al. Spontaneous regression of optic gliomas: thirteen cases documented by serial neuroimaging. Arch Ophthalmol 2001; 119:516-29.
47. Pirzkall A, Nelson S, et al. Metabolic imaging of low-grade gliomas with three-dimensional magnetic resonance spectroscopy. Int J Radiat Oncol Biol Phys 2002; 53:1254-64.
48. Rush J, Younge B, et al. Optic glioma. Long-term follow-up of 85 histopathologically verified cases. Ophthalmology 1982; 89:1213-9.
49. Saran F, Baumert B, et al. Stereotactically guided conformal radiotherapy for progressive low-grade gliomas of childhood. Int J Radiat Oncol Biol Phys 2002; 53:43-51.
50. Scott J, Brasher P, et al. How often are nonenhancing supratentorial gliomas malignant? A population study. Neurology 2002; 59:947-9.
51. Sener R. Diffusion MRI in neurofibromatosis type 1: ADC evaluations of the optic pathways, and a comparison with normal individuals. Computerized Medical Imaging and Graphics 2002; 26:59-64.
52. Singhal S, Birch J, et al. Neurofibromatosis type 1 and sporadic optic gliomas. Arch Dis Child 2002; 87:65-70.
53. Tao M, Barnes P, et al. Childhood optic chiasm gliomas: radiographic response following radiotherapy and long-term clinical outcome. Int J Radiat Oncol Biol Phys 1997; 39:579.
54. Taveras J, Mount L. The value of radiation therapy in the management of glioma of the optic nerves and chiasm. Radiology 1956; 66:518-28.
55. Tow SL, Chandela S, et al. Long-term outcome in children with gliomas of the anterior visual pathway. Pediatr Neurol 2003; 28(4):262-70.